Guardian Wealth Advisors LLC NC Has $2.12 Million Stake in Chemed Co. (NYSE:CHE)

Guardian Wealth Advisors LLC NC boosted its position in shares of Chemed Co. (NYSE:CHE - Free Report) by 26.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 3,994 shares of the company's stock after purchasing an additional 829 shares during the quarter. Guardian Wealth Advisors LLC NC's holdings in Chemed were worth $2,116,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently modified their holdings of CHE. Neuberger Berman Group LLC grew its holdings in shares of Chemed by 1.2% during the 4th quarter. Neuberger Berman Group LLC now owns 501,562 shares of the company's stock worth $265,726,000 after purchasing an additional 5,809 shares during the period. Geode Capital Management LLC increased its holdings in Chemed by 1.5% in the 4th quarter. Geode Capital Management LLC now owns 340,409 shares of the company's stock valued at $180,654,000 after purchasing an additional 4,966 shares in the last quarter. FMR LLC lifted its stake in shares of Chemed by 18.9% during the fourth quarter. FMR LLC now owns 283,790 shares of the company's stock worth $150,352,000 after purchasing an additional 45,174 shares in the last quarter. JPMorgan Chase & Co. boosted its position in shares of Chemed by 8.2% in the fourth quarter. JPMorgan Chase & Co. now owns 266,786 shares of the company's stock worth $141,343,000 after buying an additional 20,310 shares during the period. Finally, Epoch Investment Partners Inc. grew its stake in shares of Chemed by 5.1% in the fourth quarter. Epoch Investment Partners Inc. now owns 252,237 shares of the company's stock valued at $133,635,000 after buying an additional 12,167 shares in the last quarter. Hedge funds and other institutional investors own 95.85% of the company's stock.

Insider Activity at Chemed

In other Chemed news, CEO Kevin J. Mcnamara sold 1,000 shares of the business's stock in a transaction on Monday, March 31st. The shares were sold at an average price of $615.33, for a total value of $615,330.00. Following the sale, the chief executive officer now owns 101,679 shares of the company's stock, valued at $62,566,139.07. The trade was a 0.97% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Spencer S. Lee sold 1,500 shares of the company's stock in a transaction on Wednesday, May 7th. The shares were sold at an average price of $577.86, for a total value of $866,790.00. Following the completion of the sale, the executive vice president now owns 16,127 shares in the company, valued at $9,319,148.22. This trade represents a 8.51% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 6,000 shares of company stock valued at $3,534,135. Corporate insiders own 3.29% of the company's stock.

Analyst Upgrades and Downgrades

CHE has been the topic of a number of analyst reports. Royal Bank of Canada lifted their target price on Chemed from $667.00 to $674.00 and gave the stock an "outperform" rating in a research report on Monday, April 28th. StockNews.com upgraded shares of Chemed from a "hold" rating to a "buy" rating in a research note on Friday, March 7th.

Chemed Stock Performance

Shares of CHE traded down $5.76 during mid-day trading on Tuesday, reaching $563.35. 7,746 shares of the company's stock traded hands, compared to its average volume of 100,035. Chemed Co. has a 12 month low of $512.12 and a 12 month high of $623.61. The business's 50-day moving average price is $588.76 and its 200-day moving average price is $564.63. The stock has a market capitalization of $8.24 billion, a P/E ratio of 28.51, a price-to-earnings-growth ratio of 2.15 and a beta of 0.59.

Chemed (NYSE:CHE - Get Free Report) last announced its quarterly earnings data on Wednesday, April 23rd. The company reported $5.63 EPS for the quarter, beating analysts' consensus estimates of $5.59 by $0.04. Chemed had a return on equity of 27.86% and a net margin of 12.69%. The company had revenue of $646.94 million during the quarter, compared to the consensus estimate of $641.78 million. During the same quarter in the prior year, the firm earned $5.20 EPS. The company's quarterly revenue was up 9.8% compared to the same quarter last year. Equities research analysts anticipate that Chemed Co. will post 21.43 EPS for the current year.

Chemed Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, February 24th were paid a dividend of $0.50 per share. The ex-dividend date was Monday, February 24th. This represents a $2.00 annualized dividend and a dividend yield of 0.36%. Chemed's dividend payout ratio (DPR) is presently 9.74%.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.